Skip to main content
. Author manuscript; available in PMC: 2013 Aug 23.
Published in final edited form as: Nat Neurosci. 2010 Sep 27;13(10):1161–1169. doi: 10.1038/nn.2647

Table 1.

Approaches to constructing animal models of neuropsychiatric disorders

General approach Specific method Strengths Weaknesses
Genetics Selective breeding Focus on phenotypes of interest May produce a phenocopy of human disorder
Random mutation and screening Focus on phenotypes of interest May produce a phenocopy of human disorder
Transgenic animals (e.g., knock-outs, knock-ins, overexpressors) Recapitulates genetic abnormality in human disorder;
Focus on gene of interest
Variable penetrance of genetic abnormality in rodents.
Human relevance of phenotype may be difficult to establish
Virally mediated gene delivery to brain Spatial and temporal control over genetic change;
Focus on gene of interest
Does not recapitulate genetic cause of human disorder
Pharmacological Administration of neurotransmitter agonist or antagonist Temporal and some spatial (with intracranial delivery) control;
Focus on neurotransmitter system of interest
Lack of evidence that common mental disorders involve selective lesions of a single neurotransmitter system
Environmental Chronic social stress (adult or during development) May recapitulate risk factors in humans Lack of specificity for a given human disorder
Chronic physical stress Easy to administer Lack of construct validity for most human disorders
Electrical stimulation and lesions Brain stimulation, including optogenetic approaches Spatial and temporal control over neural circuit function;
May recapitulate some findings in humans with DBS
Current limitations in knowledge of neural circuit abnormalities in human disorder
Anatomical lesions May produce behavioral abnormalities reminiscent of human disorder Lack of evidence for anatomical lesions as cause of human disorder